AML is a fast-growing cancer of the blood and bone marrow, most often seen in older adults. Many patients can't tolerate traditional chemotherapy, so doctors treat them with venetoclax plus HMA.

The FDA has expanded the indication for Tibsovo to include treatment of newly diagnosed acute myeloid leukemia with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA ...

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

SYRACUSE, N.Y., Feb. 14, 2011 (GLOBE NEWSWIRE) -- Anaren, Inc. (Nasdaq:ANEN) and AML Communications, Inc. (OTCBB:AMLJ) today jointly announced the signing of a definitive merger agreement whereby ...

The approval of Tibsovo was based on an open-label, single-arm, multicenter clinical trial (Study AG120-C-001) involving 174 patients with relapsed or refractory AML with an IDH1 miutation.

DUBLIN, Feb. 15, 2018 /PRNewswire/ -- The 'Acute Myeloid Leukemia Pricing, Reimbursement, and Access' report has been added to ResearchAndMarkets.

AML has been available for the emergency number 110 "since the beginning of October 2024 across the board in the control centers", the deputy press spokesperson from the Hessian Ministry of the ...

Older patients with acute myeloid leukemia (AML) often aren't healthy enough to receive intensive chemotherapy, and gentler treatments aren't very effective in treating this aggressive blood cancer.

(RTTNews) - Novartis (NVS) said that the European Commission has approved Scemblix (asciminib) for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in ...

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly ...

Avionica, in collaboration with L2 Aviation, has earned an Approved Model List STC (AML-STC) from the FAA for the miniQAR (quick access recorder) and avCM (cellular module).